| Quarterly Financials | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
Revenue  | 55 | 65 | 69 | 69 | 66 | 77 | 82 |
| Expenses | 46 | 52 | 54 | 54 | 55 | 64 | 61 |
| EBITDA | 9 | 13 | 15 | 15 | 10 | 13 | 21 |
| Operating Profit % | 16 % | 16 % | 20 % | 21 % | 15 % | 15 % | 24 % |
| Depreciation | 1 | 3 | 4 | 3 | 2 | 4 | 5 |
| Interest | 1 | 1 | 1 | 1 | 1 | 2 | 5 |
| Profit Before Tax | 7 | 9 | 10 | 11 | 7 | 8 | 12 |
| Tax | 2 | 3 | 3 | 3 | 2 | 3 | 4 |
| Net Profit | 4 | 6 | 6 | 8 | 5 | 5 | 8 |
| EPS in ₹ | 2.10 | 2.64 | 2.37 | 3.19 | 1.86 | 2.01 | 3.07 |
Chandan Healthcare
Chandan Healthcare
235.60
-4.40
(-1.83%)
Market Cap
576.10 Cr
PE Ratio
22.87
Volume
41,600.00
Day High - Low
242.30 - 234.00
52W High-Low
358.00 - 185.40
Key Fundamentals
Market Cap
576.10 Cr
EPS
11.07
PE Ratio
22.87
PB Ratio
3.39
Book Value
69.48
EBITDA
49.65
Dividend Yield
0.00 %
Industry
Healthcare Services Sector
Healthcare Service Provider Return on Equity
18.60
Debt to Equity
0.51
Actual
Company News
View All News
Dayal Institute of Medical Sciences withdraws complaint against Chandan Healthcare after amicable settlement. Dispute over financial irregularities resolved.
Chandan Healthcare holds investor meeting
Jul 02, 2026
Jul 02, 2026Chandan Healthcare Limited conducted a virtual analysts' and investors' meeting on June 30, 2026. The session followed a Q&A format with no presentation or UPSI shared.
Chandan Healthcare reported a 20.4% rise in FY26 total income to ₹280.67 Cr, with PAT growing 21.4% to ₹27.06 Cr. EBITDA surged 31% to ₹56.84 Cr.
View more
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
1,889.40 | #1 31,673.50 | 58.02 | #1 2,864.20 | 12.11 | #1 510 | 27.24 | 56.92 | |
1,498.40 | 15,418.00 | 82.26 | 814.20 | 16.36 | 182 | 37.56 | 64.86 | |
540.80 | 11,212.30 | 55.28 | 1,671.40 | 24.15 | 191 | 25.61 | 40.60 | |
566.70 | 9,019.90 | 51.33 | 846.00 | 20.48 | 163 | 33.94 | 44.41 | |
674.15 | 6,764.50 | 79.75 | 1,023.40 | 32.93 | 77 | 35.02 | 46.80 | |
550.00 | 1,784.10 | 18.30 | 772.77 | 4.05 | 106 | -19.51 | 49.12 | |
305.15 | 1,589.20 | 45.30 | 310.41 | 21.30 | 34 | 40.22 | 68.25 | |
564.10 | 1,102.40 | #1 14.94 | 498.18 | #1 237.06 | 69 | #1 45.92 | - | |
1,151.10 | 988.00 | 17.37 | 141.92 | 27.17 | 61 | -28.57 | 38.78 | |
302.40 | 961.90 | -37.13 | 1,319.27 | 12.68 | -3 | -92.48 | 47.89 |
Automatic Screeners on ScanX
Growth Rate
Revenue Growth
19.03 %
Net Income Growth
23.11 %
Cash Flow Change
-2,693.75 %
ROE
-50.39 %
ROCE
-40.71 %
EBITDA Margin (Avg.)
-5.35 %
Quarterly Financial Results
Balance Sheet
| Balance Sheet | 2021 | 2022 | 2023 | 2024 | 2025 |
| Total Assets | 65 | 82 | 98 | 118 | 211 |
| Fixed Assets | 20 | 29 | 33 | 49 | 76 |
| Current Assets | 37 | 43 | 54 | 61 | 110 |
| Capital Work in Progress | 0 | 0 | 0 | 0 | 4 |
| Investments | 0 | 0 | 3 | 0 | 0 |
| Other Assets | 45 | 52 | 63 | 70 | 130 |
| Total Equity & Liabilities | 65 | 82 | 98 | 118 | 211 |
| Current Liabilities | 33 | 45 | 57 | 58 | 57 |
| Non Current Liabilities | 8 | 10 | 12 | 17 | 27 |
| Total Equity | 24 | 27 | 30 | 44 | 126 |
| Reserve & Surplus | 4 | 4 | 7 | 21 | 98 |
| Share Capital | 20 | 20 | 20 | 20 | 25 |
Cash Flow
| Cash Flow | 2022 | 2023 | 2024 | 2025 |
| Net Cash Flow | -1 | 1 | 2 | 2 |
| Investing Activities | -11 | -7 | -15 | -36 |
| Operating Activities | 6 | 5 | 1 | -29 |
| Financing Activities | 4 | 3 | 16 | 67 |
Share Holding
| % Holding | Sept 2024 | Feb 2025 | Mar 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| Promoter | 69.93 % | 49.20 % | 49.43 % | 49.47 % | 49.47 % | 49.55 % | 49.61 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.01 % | 0.01 % |
| DIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 4.76 % | 5.03 % | 5.09 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 0.00 % | 32.39 % | 33.00 % | 37.07 % | 39.93 % | 39.50 % | 39.10 % |
| Others | 30.07 % | 18.41 % | 17.56 % | 13.46 % | 5.84 % | 5.92 % | 6.19 % |
| No of Share Holders | 59 | 59 | 897 | 1,307 | 1,464 | 1,624 | 1,591 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 29 Aug 2026 |  Extraordinary General Meeting | NA | 29 Aug 2026 | 240.75 | 235.60 |
| 27 May 2025 |  Quarterly Result Announcement | NA | 27 May 2025 | 173.95 | 182.40 |
| 06 Nov 2025 | Extraordinary General Meeting | NA | 06 Nov 2025 | 302.40 | 332.90 |
| 14 Nov 2025 | Quarterly Result Announcement | NA | 14 Nov 2025 | 332.90 | 311.65 |
| 14 Feb 2026 | Quarterly Result Announcement | NA | 14 Feb 2026 | 271.85 | 284.50 |
| 29 May 2026 | Quarterly Result Announcement | NA | 29 May 2026 | 233.95 | 233.90 |
| 14 Aug 2026 | Quarterly Result Announcement | NA | 14 Aug 2026 | 238.05 | 241.40 |
Technical Indicators
RSI(14)
Neutral 46.41
ATR(14)
Less Volatile 11.87
STOCH(9,6)
Neutral 54.17
STOCH RSI(14)
Neutral 34.97
MACD(12,26)
Bearish -0.17
ADX(14)
Weak Trend 11.06
UO(9)
Bearish 51.17
ROC(12)
Downtrend And Accelerating -7.77
WillR(14)
Neutral -68.78
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
